Biofrontera Inc. has been notified by The Nasdaq Stock Market of its failure to meet the continued listing requirement under Nasdaq Listing Rule 5550(b)(1). As of May 21, 2025, the company's stockholders' equity was reported at $469,000, falling short of the minimum $2,500,000 requirement. Additionally, Biofrontera did not satisfy alternative criteria including a $35 million market value of listed securities or a net income of $500,000. The notice does not immediately affect trading of Biofrontera's securities. The company has 45 days to submit a compliance plan and, if accepted, could have up to 180 days to meet the requirements. If the plan is rejected, Biofrontera can appeal to a Nasdaq Hearings Panel.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.